Suscribirse

Summary of the Keystone Symposium “Origins of allergic disease: Microbial, epithelial and immune interactions,” March 24-27, Tahoe City, California - 06/04/20

Doi : 10.1016/j.jaci.2019.11.048 
Rosemarie H. DeKruyff, PhD a, b, , Wenming Zhang, PhD a, b, Kari C. Nadeau, MD, PhD a, b, Donald Y.M. Leung, MD, PhD c, Marsha Wills-Karp, PhD d
a Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, Calif 
b Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif 
c Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, National Jewish Health, Denver, Colo 
d Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md 

Corresponding author: Rosemarie H. DeKruyff, PhD, Department of Medicine, Stanford University, Stanford, CA 94305.Department of MedicineStanford UniversityStanfordCA94305

Abstract

The aims of the Keystone Symposium conference, “Origins of allergic disease: Microbial, epithelial and immune interactions” were to present and discuss potential microbial-epithelial-immune interactions underlying the early-life origins of allergic disorders, as well as immune mechanisms that might suggest novel disease prevention or intervention strategies. Cross-talk and sharing of ideas among participating experts in basic science and clinical aspects of allergic diseases provided substantial insight into the concept of allergic disorders as a systems disease. The overriding message distilled from the discussions was that damage to epithelial surfaces lies at the origin of the various manifestations of allergic disease. The epithelium of the lungs, gut, and skin, which operates as a critical sensor of environmental stimuli, is besieged by an onslaught of contemporary environmental forces including an altered microbiome, air pollution, food allergens in a changed diet, and chemicals in modern detergents. Collectively, this onslaught leads to alterations of lung, skin, or gut epithelial surfaces, driving a type 2 immune response that underlies most, if not all, of the atopic diseases. Possible remedies for treatment and prevention of allergic diseases were discussed, including a precision medicine approach using biologics, oral desensitization, targeted gut microbiome alterations, and behavior alteration.

El texto completo de este artículo está disponible en PDF.

Key words : Atopic dermatitis, food allergy, asthma, microbiome, epithelial barrier

Abbreviations used : AD, CC16, CMA, DC, EoE, FA, FLG, LoF, NPM, RV, TSLP


Esquema


 This work was supported by the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, California (R.H.D., W.Z., and K.C.N.). D.Y.M.L. is supported by National Institutes of Health grants 1U19AI117673, 5R01AR41256, UL1TR002535, 1UM2AI130836, and UM1AI130780.
 Disclosure of potential conflict of interest: K. C. Nadeau reports grants from the National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education (FARE), End Allergies Together, Allergenis, and Ukko Pharma; is grant awardee at NIAID, National Institute of Environmental Health Sciences, National Heart, Lung, and Blood Institute (NHLBI), and the Environmental Protection Agency; is involved in clinical trials with Regeneron, Genentech, AImmune Therapeutics, DBV Technologies, AnaptysBio, Adare Pharmaceuticals, and Stallergenes Greer; received research sponsorship by Novartis, Sanofi, Astellas, and Nestle; is Data and Safety Monitoring Board member at Novartis and NHLBI; cofounded BeforeBrands, Alladapt, ForTra, and Iggenix; is Director of FARE and World Allergy Organization (WAO) Center of Excellence; and received personal fees from Regeneron, Astrazeneca, ImmuneWorks, and Cour Pharmaceuticals. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 145 - N° 4

P. 1072 - avril 2020 Regresar al número
Artículo precedente Artículo precedente
  • On the cause and consequences of IgE to galactose-?-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy
  • Thomas A.E. Platts-Mills, Scott P. Commins, Tilo Biedermann, Marianne van Hage, Michael Levin, Lisa A. Beck, Maria Diuk-Wasser, Uta Jappe, Danijela Apostolovic, Michael Minnicozzi, Marshall Plaut, Jeffrey M. Wilson
| Artículo siguiente Artículo siguiente
  • Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
  • Marcus S. Shaker, Dana V. Wallace, David B.K. Golden, John Oppenheimer, Jonathan A. Bernstein, Ronna L. Campbell, Chitra Dinakar, Anne Ellis, Matthew Greenhawt, David A. Khan, David M. Lang, Eddy S. Lang, Jay A. Lieberman, Jay Portnoy, Matthew A. Rank, David R. Stukus, Julie Wang, Collaborators, Natalie Riblet, Aiyana M.P. Bobrownicki, Teresa Bontrager, Jarrod Dusin, Jennifer Foley, Becky Frederick, Eyitemi Fregene, Sage Hellerstedt, Ferdaus Hassan, Kori Hess, Caroline Horner, Kelly Huntington, Poojita Kasireddy, David Keeler, Bertha Kim, Phil Lieberman, Erin Lindhorst, Fiona McEnany, Jennifer Milbank, Helen Murphy, Oriana Pando, Ami K. Patel, Nicole Ratliff, Robert Rhodes, Kim Robertson, Hope Scott, Audrey Snell, Rhonda Sullivan, Varahi Trivedi, Azadeh Wickham, Chief Editors, Marcus S. Shaker, Dana V. Wallace, Workgroup Contributors, Marcus S. Shaker, Dana V. Wallace, Jonathan A. Bernstein, Ronna L. Campbell, Chitra Dinakar, Anne Ellis, David B.K. Golden, Matthew Greenhawt, Jay A. Lieberman, Matthew A. Rank, David R. Stukus, Julie Wang, Joint Task Force on Practice Parameters Reviewers, Marcus S. Shaker, Dana V. Wallace, David B.K. Golden, Jonathan A. Bernstein, Chitra Dinakar, Anne Ellis, Matthew Greenhawt, Caroline Horner, David A. Khan, Jay A. Lieberman, John Oppenheimer, Matthew A. Rank, Marcus S. Shaker, David R. Stukus, Julie Wang

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.